Primary Discoid Lupus Erythematosus clinical trials

Explore recruiting primary discoid lupus erythematosus clinical trials.

Also recruiting in Europe

Primary Discoid Lupus Erythematosus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

Denmark, France, Czechia, Germany, Poland, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Primary Discoid Lupus Erythematosus trials by city

Primary Discoid Lupus Erythematosus in Toronto Primary Discoid Lupus Erythematosus in Vancouver Primary Discoid Lupus Erythematosus in Montreal Primary Discoid Lupus Erythematosus in Calgary Primary Discoid Lupus Erythematosus in Edmonton Primary Discoid Lupus Erythematosus in Ottawa Primary Discoid Lupus Erythematosus in Winnipeg Primary Discoid Lupus Erythematosus in Quebec City Primary Discoid Lupus Erythematosus in Hamilton Primary Discoid Lupus Erythematosus in Kitchener Primary Discoid Lupus Erythematosus in London Primary Discoid Lupus Erythematosus in Halifax Primary Discoid Lupus Erythematosus in New York Primary Discoid Lupus Erythematosus in Los Angeles Primary Discoid Lupus Erythematosus in Chicago Primary Discoid Lupus Erythematosus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease